<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30180205</article-id>
<article-id pub-id-type="pmc">6122816</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0203543</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-34784</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Experimental Organism Systems</subject>
<subj-group>
<subject>Model Organisms</subject>
<subj-group>
<subject>Zebrafish</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Model Organisms</subject>
<subj-group>
<subject>Zebrafish</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Experimental Organism Systems</subject>
<subj-group>
<subject>Animal Models</subject>
<subj-group>
<subject>Zebrafish</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Organisms</subject>
<subj-group>
<subject>Eukaryota</subject>
<subj-group>
<subject>Animals</subject>
<subj-group>
<subject>Vertebrates</subject>
<subj-group>
<subject>Fish</subject>
<subj-group>
<subject>Osteichthyes</subject>
<subj-group>
<subject>Zebrafish</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Social Sciences</subject>
<subj-group>
<subject>Psychology</subject>
<subj-group>
<subject>Developmental Psychology</subject>
<subj-group>
<subject>Pervasive Developmental Disorders</subject>
<subj-group>
<subject>Autism Spectrum Disorder</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Cell Biology</subject>
<subj-group>
<subject>Cellular Structures and Organelles</subject>
<subj-group>
<subject>Cytoskeleton</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Gene Expression</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Biological Locomotion</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Biological Locomotion</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biophysics</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Physical Sciences</subject>
<subj-group>
<subject>Physics</subject>
<subj-group>
<subject>Biophysics</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Neurophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Physiology</subject>
<subj-group>
<subject>Electrophysiology</subject>
<subj-group>
<subject>Neurophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
<subj-group>
<subject>Neurophysiology</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
<subj-group>
<subject>Proteins</subject>
<subj-group>
<subject>Ion Channels</subject>
<subj-group>
<subject>Ligand-Gated Ion Channels</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Experimental Organism Systems</subject>
<subj-group>
<subject>Animal Models</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Transcriptome Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Transcriptome Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Plausibility of the zebrafish embryos/larvae as an alternative animal model for autism: A comparison study of transcriptome changes</article-title>
<alt-title alt-title-type="running-head">Zebrafish embryos/larvae for autism</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Sangwoo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chun</surname>
<given-names>Hang-Suk</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Jieon</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Han-Jin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Ki-Tae</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Cheol-Hee</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoon</surname>
<given-names>Seokjoo</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8355-4057</contrib-id>
<name>
<surname>Kim</surname>
<given-names>Woo-Keun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label>
<addr-line>System Toxicology Research Center, Korea Institute of Toxicology, Daejeon, Republic of Korea</addr-line></aff>
<aff id="aff002"><label>2</label>
<addr-line>Predictive Model Research Center, Korea Institute of Toxicology, Daejeon, Republic of Korea</addr-line></aff>
<aff id="aff003"><label>3</label>
<addr-line>Department of Environmental Engineering, Seoul National University of Science and Technology, Seoul, Republic of Korea</addr-line></aff>
<aff id="aff004"><label>4</label>
<addr-line>Department of Biology, Chungnam National University, Daejeon, Republic of Korea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Burgess</surname>
<given-names>Harold A.</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>National Institutes of Health, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email>wookkim@kitox.re.kr</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>4</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<issue>9</issue>
<elocation-id>e0203543</elocation-id>
<history>
<date date-type="received">
<day>26</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 Lee et al</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Lee et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0203543.pdf"></self-uri>
<abstract>
<p>Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder characterized by impaired or abnormal social interaction and communication and by restricted and repetitive behaviour. ASD is highly prevalent in Asia, Europe, and the United States, and the frequency of ASD is growing each year. Recent epidemiological studies have indicated that ASD may be caused or triggered by exposure to chemicals in the environment, such as those in the air or water. Thus, toxicological studies are needed to examine chemicals that might be implicated. However, the experimental efficiency of existing experimental models is limited, and many models represent challenges in terms of animal welfare. Thus, alternative ASD animal models are necessary. To address this, we examined the efficacy of the zebrafish embryo/larva as an alternative model of ASD. Specifically, we exposed zebrafish to valproic acid (0, 12.5, 25, 50, or 100 μM), which is a chemical known to induce autism-like effects. We then analysed subsequent developmental, behavioural, and transcriptomic changes. We found that 100 μM and 50 μM valproic acid decreased the hatching rate and locomotor activity of zebrafish embryos/larvae. Transcriptomic analysis revealed significant alterations in a number of genes associated with autism, such as <italic>adsl</italic>, <italic>mbd5</italic>, <italic>shank3</italic>, and <italic>tsc1b</italic>. Additionally, we found changes in gene ontology that were also reported in previous studies. Our findings indicate that zebrafish embryos/larvae and humans with ASD might have common physiological pathways, indicating that this animal model may represent an alternative tool for examining the causes of and potential treatments for this illness.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003705</institution-id>
<institution>Korea Institute of Toxicology</institution>
</institution-wrap>
</funding-source>
<award-id>kk-1704</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8355-4057</contrib-id>
<name>
<surname>Kim</surname>
<given-names>Woo-Keun</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003705</institution-id>
<institution>Korea Institute of Toxicology</institution>
</institution-wrap>
</funding-source>
<award-id>kk-1701-01</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8355-4057</contrib-id>
<name>
<surname>Kim</surname>
<given-names>Woo-Keun</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This study was supported by the projects entitled “Development of alternative fish toxicity test methods using zebrafish embryo (KK-1704)” and “Development of predicting platforms for human toxicity by BIT technology (KK-1701-01) funded by Korea Institute of Toxicology (KIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<page-count count="21"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>All relevant data are within the paper and its Supporting Information files.</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is an early onset neuropsychiatric disorder that is characterized by impaired social communication, restricted interests, and stereotyped and repetitive behaviours [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>]. Recent years have seen a dramatic increase in the prevalence of ASD in Asia, Europe, and the USA. The prevalence of ASD in Sweden (Stockholm cohort study) increased by almost 3.5-fold between 2001 and 2011 [<xref ref-type="bibr" rid="pone.0203543.ref003">3</xref>], and the prevalence in the United States increased from 1 in 150 children in 2002 to 1 in 68 children in 2012 [<xref ref-type="bibr" rid="pone.0203543.ref004">4</xref>]. The prevalence of ASD in South Korea has been found to be as high as 2.64% (95% CI = 1.91–3.37) [<xref ref-type="bibr" rid="pone.0203543.ref005">5</xref>]. Accordingly, the aetiology of ASD has been the subject of increasing focus [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>–<xref ref-type="bibr" rid="pone.0203543.ref011">11</xref>]. Previous studies have described key genes and pathways associated with ASD that may be linked to synaptic scaffolding proteins, receptors, and cell adhesion molecules involved in chromatin remodelling, transcription, protein synthesis or degradation, and actin cytoskeleton dynamics [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>]. Key genes involved in ASD are thought to include <italic>eif4</italic>, <italic>GABA a receptor</italic>, <italic>mecp2</italic>, <italic>neurexin</italic>, <italic>neuroligins</italic>, and <italic>shank</italic> [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203543.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0203543.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0203543.ref014">14</xref>].</p>
<p>Although 54% of the rapid increase in ASD prevalence could be explained by diagnostic accretion, greater awareness, and increased parental age, the remaining portion of the increase is unexplained, indicating that an environmental agent may play a role [<xref ref-type="bibr" rid="pone.0203543.ref015">15</xref>]. Recently, epidemiological studies have produced evidence of a relationship between environmental pollutants and ASD [<xref ref-type="bibr" rid="pone.0203543.ref016">16</xref>–<xref ref-type="bibr" rid="pone.0203543.ref021">21</xref>]. A systematic review paper also showed that the aetiology of ASD may involve complex interactions between genetic factors and certain environmental toxicants [<xref ref-type="bibr" rid="pone.0203543.ref022">22</xref>]. For example, exposure to ambient air pollution and particulate matter with diameters ≤ 2.5 μm may be associated with ASD [<xref ref-type="bibr" rid="pone.0203543.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0203543.ref020">20</xref>]. Proximity to industrial facilities releasing arsenic, lead, or mercury has also been associated with ASD prevalence [<xref ref-type="bibr" rid="pone.0203543.ref018">18</xref>]. In addition, common agricultural pesticides (organophosphates and pyrethroids) and endocrine disrupting chemicals (polybrominated diphenyl ether-28 and <italic>trans</italic>-nonachlor) might increase the prevalence of ASD [<xref ref-type="bibr" rid="pone.0203543.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0203543.ref023">23</xref>]. Although children today are surrounded by thousands of synthetic chemicals, specific environmental chemicals that are linked to ASD prevalence have not been identified [<xref ref-type="bibr" rid="pone.0203543.ref024">24</xref>]. Few studies have examined the ASD-inducing effects of environmental chemicals, especially in terms of experimental toxicity. Furthermore, fewer than 20% of the high-volume chemicals for which epidemiological relationships with ASD have been reported have been tested for neurodevelopmental toxicity [<xref ref-type="bibr" rid="pone.0203543.ref024">24</xref>]. Therefore, experimental studies are required to examine the causal relationship between environmental chemical exposure and ASD.</p>
<p>To this end, experimental animal models are an indispensable tool [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>]. Animal models for use in ASD research are mostly limited to rodents because of their robust behavioural phenotype and comprehensive genetic characterization [<xref ref-type="bibr" rid="pone.0203543.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0203543.ref027">27</xref>]. However, there is a growing need for models that are time and cost efficient, satisfy animal welfare criteria and are high throughput to screen the ASD-related toxicity of environmental chemicals and to identify effective pharmaceutical treatments for ASD from a massive chemical library [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>]. The zebrafish (<italic>Danio rerio</italic>) is a new popular model organism in biomedical research [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>]. The utility of both adult and larval zebrafish in neuroscience has grown markedly because it is a vertebrate species with high physiologic and genetic homology to humans and similar central nervous system (CNS) morphology [<xref ref-type="bibr" rid="pone.0203543.ref028">28</xref>]. Additionally, zebrafish have high fecundity (200–300 eggs per pair of adult fish) and produce a small-sized egg, which fits easily into a single well in a 96- or 384-well plate for high-throughput tests [<xref ref-type="bibr" rid="pone.0203543.ref029">29</xref>]. Thus, zebrafish are emerging as a new alternative model for ASD research [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0203543.ref028">28</xref>, <xref ref-type="bibr" rid="pone.0203543.ref030">30</xref>]. However, transcriptome analysis and comparison studies focused on ASD have not yet been conducted with the zebrafish model [<xref ref-type="bibr" rid="pone.0203543.ref031">31</xref>–<xref ref-type="bibr" rid="pone.0203543.ref034">34</xref>].</p>
<p>Therefore, we designed the present study to evaluate the use of zebrafish as an alternative model for ASD research. We analysed developmental, behavioural, and transcriptomic changes and compared transcriptome data from zebrafish after exposure to valproic acid (VPA, an ASD inducer) with those from human ASD patients and a mouse model.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec003">
<title>Maintenance of zebrafish</title>
<p>Wild-type zebrafish (5D line) were generously provided by Robert L. Tanguay (Oregon State University, Corvallis, OR, USA) and maintained in a temperature-controlled room (25 ± 1°C) under a 14:10 h light:dark photoperiod. The zebrafish embryos used in the present study were obtained from mating pairs of adult zebrafish. The embryos were collected and examined under a stereomicroscope.</p>
</sec>
<sec id="sec004">
<title>Test chemical and exposure experiments</title>
<p>Valproic acid sodium salt (2-propylpentanoic acid sodium, CAS RN. 1069-66-5, purity &gt; 98%) was purchased from Sigma-Aldrich (St. Louis, MO, USA). The test solutions were prepared in E3 medium, 0.292 g NaCl, 0.013 g KCl, 0.044 g CaCl, and 0.081 g MgSO<sub>4</sub> in Millipore water (1 L). The exposure concentrations (0, 12.5, 25, 50, 100 μM of VPA) were determined according to previous studies [<xref ref-type="bibr" rid="pone.0203543.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0203543.ref034">34</xref>]. Normal zebrafish embryos were randomly distributed into test solutions of VPA for 120 h. All exposure experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committee (IACUC) of the Korea Institute of Toxicology (Protocol No. RS16005).</p>
</sec>
<sec id="sec005">
<title>Survival, hatching status, and malformation</title>
<p>During the exposure period, embryo/larva survival, hatching rate, time to hatch, and morphological malformation rate were checked every 24 h until 120 h. Percentages corresponding to mortality, hatching rate, and malformation rate were determined in quadruplicate (N = 4), with six embryos in each sample.</p>
</sec>
<sec id="sec006">
<title>Locomotor activity (movement tracking)</title>
<p>After 120 h exposure to VPA, we monitored the movement of each fish via an automated tracking device, Zebrabox™ (Viewpoint, Lyon, France). We tracked the larvae per treatment with octuplicates (N = 8) including three larvae in each. Tracking occurred during 4 repeated phases of a 3-min light/3-min dark period for a total of 24 min. The video data were then analysed using ZebraLab™ software to calculate the total distance travelled and active duration rate ((total movement duration–inactive duration) / total duration) for each individual larva.</p>
</sec>
<sec id="sec007">
<title>RNA-seq analysis</title>
<p>After 72 h and 120 h exposure, we pooled twenty zebrafish larvae per sample for RNA extraction. Triplicate (N = 3) pooled RNA samples from each treatment group were prepared and kept in RNA<italic>later</italic> RNA stabilization solution (Qiagen, Hilden, Germany) for further RNA extraction. Total RNA was isolated using the RNeasy mini kit (Qiagen, Hilden, Germany). We assessed rRNA band integrity using an Agilent RNA 6000 Nano kit (Agilent Technologies, CA, USA). We used samples with an RNA Integrity Number (RIN) greater than 7 for RNA library construction. Briefly, prior to cDNA library construction, we used 1 μg of total RNA and magnetic beads with oligo (dT) to enrich the poly (A) mRNA. Then, the purified mRNA was disrupted into short fragments, and the double-stranded cDNA was immediately synthesized. The cDNA was subjected to end-repair, poly (A) addition, and connected with sequencing adapters using the TruSeq RNA Sample Prep Kit (Illumina, Ca, USA). The suitable fragments, purified via a BluePippin 2% agarose gel cassette (Sage Science, MA, USA), were selected as templates for PCR amplification. The final libraries were quantified using a KAPA library quantification kit (KAPA Biosystems, South Africa), and the quality of the library was evaluated using an Agilent 2100 bioanalyser (Agilent Technologies, CA, USA). The fragments were found to contain between 350 and 450 base pairs. Subsequently, the library was sequenced using an Illumina HiSeq2500 sequencing platform (Illumina, CA, USA). Low-quality reads were filtered according to the following criteria: reads contained more than 10% skipped bases, reads contained more than 40% of bases whose quality scores are less than 20, and reads with average quality scores of each read less than 20. The filtered reads were mapped to the zebrafish reference genome (Ensembl version 86) using the aligner STAR v.2.3.0e [<xref ref-type="bibr" rid="pone.0203543.ref035">35</xref>].</p>
</sec>
<sec id="sec008">
<title>DEG analysis and GO analysis</title>
<p>We measured the gene expression level using Cufflinks v2.1.1 [<xref ref-type="bibr" rid="pone.0203543.ref036">36</xref>] with the gene annotation database from Ensembl version 86. The non-coding gene region was removed with the mask option. To improve the accuracy of measurement, we applied multi-read correction and frag bias correction. The abundance of gene transcripts was measured via FPKM (fragments per kilobase of transcript per million fragments mapped). The FPKM cut-off level was set at 0.1. For differential expression analysis, gene level count data were generated using the HTSeq-count v0.5.4p3 tool [<xref ref-type="bibr" rid="pone.0203543.ref037">37</xref>]. Using calculated read count data, differentially expressed genes (DEGs) were identified using the TCC R package [<xref ref-type="bibr" rid="pone.0203543.ref038">38</xref>]. Genes with a <italic>p</italic>-value &lt; 0.05 and | log<sub>2</sub>FC(fold change) | &gt; 1 were considered to be differentially expressed. Significantly altered DEGs were compared with the ASD-related gene lists from previous studies [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0203543.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0203543.ref039">39</xref>]. To predict the function of the selected genes, the DEGs were subjected to gene ontology (GO) according to three categories: biological process (BP), cellular component (CC), and molecular function (MF). The ontology and annotation files for GO enrichment analysis were downloaded from the gene ontology website (<ext-link ext-link-type="uri" xlink:href="http://www.geneontology.org/">http://www.geneontology.org/</ext-link>). <italic>p</italic>-values &lt; 0.001 were considered statistically significant [<xref ref-type="bibr" rid="pone.0203543.ref040">40</xref>]. Significantly altered GOs were compared with the ASD-related GO lists from previous studies [<xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref041">41</xref>]. Concentration-dependent changes in GO enrichment were determined based on the gene lists showing transcriptional changes over 2 (| log<sub>2</sub>FC | &gt; 1) between at least two serial concentrations with consistent positive or negative slopes.</p>
</sec>
<sec id="sec009">
<title>Quantitative PCR analysis</title>
<p>To validate the transcriptions of DEG analysis, quantitative PCR analysis was carried out. Target genes, i.e., <italic>adsl</italic> (<italic>adenylosuccinate lyase</italic>), <italic>mbd5</italic> (<italic>methyl-CpG binding domain protein 5</italic>), <italic>shank3a</italic> (<italic>SH3 and multiple ankyrin repeat domains 3a</italic>), and <italic>tsc1b</italic> (<italic>tuberous sclerosis complex 1</italic>), were chosen based on the commonality with previous studies (<xref ref-type="table" rid="pone.0203543.t001">Table 1</xref>). After 120 h of VPA exposure, total RNA was extracted using a Maxwell 16 total RNA purification kit (Promega Co., Madison, WI, USA), and its concentration and quality were checked with an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, ED, USA). During the RNA extraction, genomic DNA was selectively removed with the clearing agent that was included in the purification kit. cDNAs were synthesized by reverse transcription using an iScript cDNA synthesis kit (BioRad, Hercules, CA, USA). The cDNA concentrations were also measured using an ND-1000 spectrophotometer. The samples were then diluted with purified water to 300 ng/μL. Target genes were amplified using an ABI 7300 RT-PCR system (Applied Biosystems, Foster City, CA, USA). The PCR reaction mixture (total 20 μ/L) contained 10 μL of ABI SYBR Green Master mix (ABI, USA), 1.8 μL of each primer (10 pmol), 4.4 μL of purified PCR-grade water, and 2 μL of cDNA sample. The thermal cycle profile was as follows: pre-incubation at 95°C for 10 min, 40 cycles of amplification at 95°C for 10 s, 60°C for 20 s, and 72°C for 20 s. The comparative Ct methods were employed to calculate the relative level of gene transcription [<xref ref-type="bibr" rid="pone.0203543.ref042">42</xref>]. The sequence of primers for the target genes and reference gene (<italic>β-actin</italic>) for zebrafish are shown in <xref ref-type="supplementary-material" rid="pone.0203543.s003">S1 Table</xref>.</p>
<table-wrap id="pone.0203543.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.t001</object-id>
<label>Table 1</label>
<caption>
<title>Commonly observed ASD-related DEGs in this and previous studies.</title>
</caption>
<alternatives>
<graphic id="pone.0203543.t001g" xlink:href="pone.0203543.t001"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="6" rowspan="1">Genes suggested by previous human studies</th>
<th align="center" colspan="1" rowspan="2">Description</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1">Voineagu <italic>et al</italic>. (2011)</th>
<th align="center" colspan="1" rowspan="1">Pinto<break></break><italic>et al</italic>. (2014)</th>
<th align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">Sanders et al. (2015)</th>
<th align="center" colspan="2" rowspan="1">Bourgeron <italic>et al</italic>. (2015)<xref ref-type="table-fn" rid="t001fn001"><sup>a)</sup></xref></th>
<th align="center" colspan="1" rowspan="1">Chang<break></break><italic>et al</italic>.<break></break>(2015)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>actn4</italic>
</td>
<td align="center" colspan="1" rowspan="1">alpha-actinin-4</td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>
<italic>adsl</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>adenylosuccinate lyase</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>capn12</italic>
</td>
<td align="center" colspan="2" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1">calcium-activate neutral proteinase 12</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>dcx (dcxr)</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">dicarbonyl/L-xylulose reductase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>ddb1</italic>
</td>
<td align="center" colspan="1" rowspan="1">damage-specific DNA binding protein 1</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>eif4a1</italic>
<break></break>
<italic>(eif4a1a)</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">eukaryotic translation initiation factor 4A1A</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>fanca</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">fanconi anaemia group A protein</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>gamt</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">guanidinoacetate N-methyltransferase</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>gatm</italic>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">glycine amidinotransferase<break></break>(L-arginine:glycine amidinotransferase)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>hsd17b10</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">hydroxysteroid (17-beta) dehydrogenase 10</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>kcnj11</italic>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">potassium inwardly rectifying channel, subfamily J, member 11</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="3" rowspan="1" style="background-color:#808080">
<bold>
<italic>mbd5</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>methyl-CpG binding domain protein 5</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>myh11</italic>
<break></break>
<italic>(myh11a)</italic>
</td>
<td align="center" colspan="1" rowspan="1">myosin, heavy chain 11a, smooth muscle</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<italic>nrxn2</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">neurexin-2</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>pde9a</italic>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">high affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>pfkm</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">6-phosphofructokinase, muscle type</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>rpe65 (rpe65a)</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF">retinal pigment epithelium-specific protein 65a</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>rpl10</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">ribosomal protein L10</td>
</tr>
<tr>
<td align="center" colspan="5" rowspan="1" style="background-color:#808080">
<bold>
<italic>shank3 (shank3a)</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">
<bold>SH3 and multiple ankyrin repeat domains 3a</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>slc6a1</italic>
</td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">solute carrier family 6, member 1, like</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>suclg2</italic>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">succinate-CoA ligase, GDP-forming, beta subunit</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>tdo2</italic>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">tryptophan 2,3-dioxygenase a</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<italic>trip12</italic>
</td>
<td align="center" colspan="2" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">thyroid hormone receptor interactor 12</td>
</tr>
<tr>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>
<italic>tsc1(tsc1b)</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>
<italic>tsc1 (tsc1b)</italic>
</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>tuberous sclerosis 1b</bold>
</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p><sup>a)</sup> Review article. DEGs were determined based on statistical significance (<italic>p</italic> &lt; 0.05). Fold changes (log<sub>2</sub>FC) for each DEG are shown in <xref ref-type="supplementary-material" rid="pone.0203543.s005">S3</xref>–<xref ref-type="supplementary-material" rid="pone.0203543.s009">S7</xref> Tables. DEGs from multiple studies are marked in bold.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec010">
<title>Statistical analysis</title>
<p>The normality and homogeneity of each variance were analysed using the Shapiro-Wilk test and Levene’s test. Then, we conducted one-way analyses of variance (ANOVA) with Dunnett’s test or T3 tests using SPSS 12 for Windows® (SPSS, Chicago, IL, USA) to determine significant differences between the control and VPA exposure groups. For non-parametric data, we used the Kruskal-Wallis test. Differences with <italic>p</italic>-values less than 0.05 were considered significant. For trend analysis, linear regression analysis was carried out, and the statistical significance of a linear trend in the slope was determined (<italic>p</italic> for trend).</p>
</sec>
</sec>
<sec id="sec011" sec-type="results">
<title>Results</title>
<sec id="sec012">
<title>Effects of VPA on survival, hatching status, and development</title>
<p>The survival of zebrafish larvae was unchanged for exposure up to 100 μM of VPA (<xref ref-type="fig" rid="pone.0203543.g001">Fig 1(A)</xref>). However, the hatching rate significantly decreased at 100 μM of VPA (<xref ref-type="fig" rid="pone.0203543.g001">Fig 1(B)</xref>) to only 29%. Time to hatch was significantly delayed at 50 μM of VPA (<xref ref-type="fig" rid="pone.0203543.g001">Fig 1(C)</xref>). We observed no significant developmental changes for exposure up to 50 μM of VPA (<xref ref-type="fig" rid="pone.0203543.g001">Fig 1(D)</xref>).</p>
<fig id="pone.0203543.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Effects of VPA on zebrafish survival, hatching status, and development.</title>
<p>NA: not available due to significantly decreased hatching rate. The results are shown as the mean ± standard deviation (N = 4). Asterisk (*) denotes statistical significance (<italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic xlink:href="pone.0203543.g001"></graphic>
</fig>
</sec>
<sec id="sec013">
<title>Effects of VPA on larval behaviour</title>
<p>VPA exposure at 50 μM caused a significant decrease in the total distance moved compared with control values (<xref ref-type="fig" rid="pone.0203543.g002">Fig 2(A)</xref>). At 50 μM VPA, the active duration ratio during the dark phase was significantly reduced to 20% of that in the control group (<xref ref-type="fig" rid="pone.0203543.g002">Fig 2(B)</xref>). However, at 25 μM VPA, the total distance moved and active duration ratio during the dark phase increased by 30% and 25%, respectively, although this was not statistically significant (<xref ref-type="fig" rid="pone.0203543.g002">Fig 2(A) and 2(B)</xref>).</p>
<fig id="pone.0203543.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.g002</object-id>
<label>Fig 2</label>
<caption>
<p><bold>Total distance moved (a) and active duration ratio (b) after 120 h VPA exposure. The error bars are marked separately for the dark and light phases.</bold> The analysis the total distance moved was determined for the sum of the distance moved during the dark and light phases. The results are shown as the mean ± SEM (N = 8, except control (N = 7)). Asterisks (*) indicate statistical significance (<italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic xlink:href="pone.0203543.g002"></graphic>
</fig>
</sec>
<sec id="sec014">
<title>Illumina sequencing and mapping of RNA sequencing reads onto the zebrafish genome</title>
<p>High-throughput sequencing generated approximately 76.5–90.8 million (M) pairs of raw reads for each group (<xref ref-type="supplementary-material" rid="pone.0203543.s004">S2 Table</xref>). From each group, 75.5–89.8 M pairs of clean reads were extracted. Then, these high-quality reads were mapped to the reference zebrafish genome over 82.3%–88.3%. The uniquely mapped reads ranged from 78.8% to 85.3%.</p>
</sec>
<sec id="sec015">
<title>Analysis of differentially expressed zebrafish genes following VPA exposure</title>
<p>The number of DEGs ranged from 921 (12.5 μM at 72 h) to 1468 (25 μM at 120 h). The number of DEGs at 25 μM and 50 μM VPA were greater than those at 12.5 μM VPA at 72 h exposure (<xref ref-type="supplementary-material" rid="pone.0203543.s001">S1 Fig</xref>). At 120 h, the number of upregulated genes was greater than that of downregulated genes. However, there were more downregulated genes than upregulated genes at 72 h for all VPA conditions except 25 μM.</p>
<p>Between 26.6% and 36.4% of the DEGs (&gt; 2-fold change) in the present study matched ASD-related genes reported in previous studies [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0203543.ref011">11</xref>] (<xref ref-type="fig" rid="pone.0203543.g003">Fig 3(A)</xref>). Among them, 24 DEGs were significant (<italic>p</italic> &lt; 0.05), as shown in <xref ref-type="table" rid="pone.0203543.t001">Table 1</xref>. The transcription of genes indicated in previous studies to be ASD-related (e.g., <italic>adsl</italic>, <italic>eif4a1</italic> (<italic>eukaryotic translation initiation factor 4a1</italic>), <italic>mbd5</italic>, <italic>nrxn2</italic> (<italic>neurexin2</italic>), <italic>shank3</italic>, and <italic>tsc1</italic>, etc.) was significantly altered. The detailed data for DEGs that were significantly differentially expressed or expressed over 2-fold (| log2FC | &gt; 1) in previous studies are shown in <xref ref-type="supplementary-material" rid="pone.0203543.s005">S3</xref>–<xref ref-type="supplementary-material" rid="pone.0203543.s009">S7</xref> Tables.</p>
<fig id="pone.0203543.g003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.g003</object-id>
<label>Fig 3</label>
<caption>
<p><bold>Commonality of (a) DEGs and (b) GOs in the present study with respect to previous studies.</bold> (a) Data from Voineagu <italic>et al</italic>. (2011), Pinto <italic>et al</italic>. (2014), Sanders <italic>et al</italic>. (2015), Bourgeron <italic>et al</italic>. (2015), and Chang <italic>et al</italic>. (2015). (b) Data from Chang <italic>et al</italic>. (2015) and Jasien <italic>et al</italic>. (2014).</p>
</caption>
<graphic xlink:href="pone.0203543.g003"></graphic>
</fig>
<p>The transcription of genes that had been commonly suggested as ASD-related genes by more than two previous studies and our study were significantly changed (<xref ref-type="fig" rid="pone.0203543.g004">Fig 4</xref>). Significant upregulation (<italic>adsl</italic> and <italic>mbd5</italic>) and downregulation (<italic>shank3a</italic> and <italic>tsb1b</italic>) were observed after 120 h VPA exposure in the qPCR analysis. Significant trends (<italic>p</italic> for trend) were also shown in the transcription of <italic>adsl</italic>, <italic>mbd5a</italic>, and <italic>shank3a</italic>.</p>
<fig id="pone.0203543.g004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Gene transcription confirmation by using qRT-PCR analysis.</title>
<p>The results are shown as the mean ± SEM (N = 4). Asterisks (*) and arrows indicate significant differences from the control and significant trend of the slope, respectively (<italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic xlink:href="pone.0203543.g004"></graphic>
</fig>
</sec>
<sec id="sec016">
<title>Analysis of GO enrichment in zebrafish after VPA exposure</title>
<p>In this study, we identified 44 GO enrichments that had been classified as ASD-related in previous studies [<xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref041">41</xref>] (<xref ref-type="table" rid="pone.0203543.t002">Table 2</xref>, <xref ref-type="supplementary-material" rid="pone.0203543.s010">S8</xref> and <xref ref-type="supplementary-material" rid="pone.0203543.s011">S9</xref> Tables). Half of the GOs were included in the CC category, and 13 and 9 of them were included in the MF and BP categories, respectively (<xref ref-type="table" rid="pone.0203543.t002">Table 2</xref>). Significantly affected GO enrichments (<italic>p</italic> &lt; 0.001) in this study were reported in 5.8% to 29.4% of previous human and mouse studies (<xref ref-type="fig" rid="pone.0203543.g003">Fig 3(B)</xref>). After VPA exposure, we found significant changes in GO enrichments related to transport (GO: 0006810), intracellular function (GO: 0005622), cytoplasm (GO: 0005737), mitochondria (GO: 0005739), cytosol (GO: 0005829), cytoskeleton (GO: 0005856), and cell projects (GO: 0042995), which are commonly found in the mouse cortex and hippocampus [<xref ref-type="bibr" rid="pone.0203543.ref041">41</xref>].</p>
<table-wrap id="pone.0203543.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.t002</object-id>
<label>Table 2</label>
<caption>
<title>Commonly observed GO enrichments in this and previous studies.</title>
</caption>
<alternatives>
<graphic id="pone.0203543.t002g" xlink:href="pone.0203543.t002"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="justify" colspan="1" rowspan="2"></th>
<th align="center" colspan="1" rowspan="2">Chang <italic>et al</italic>. (2015)<xref ref-type="table-fn" rid="t002fn001"><sup>a)</sup></xref></th>
<th align="center" colspan="2" rowspan="1">Jasien <italic>et al</italic>. (2014)<xref ref-type="table-fn" rid="t002fn002"><sup>b)</sup></xref></th>
<th align="center" colspan="1" rowspan="2">Term.</th>
</tr>
<tr>
<th align="justify" colspan="1" rowspan="1">Cortical</th>
<th align="justify" colspan="1" rowspan="1">Hippocampal</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0006091</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">generation of precursor metabolites and energy</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0006397</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">mRNA processing</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0006810</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>transport</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0006873</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cellular ion homeostasis</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016071</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">mRNA metabolic process</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0022904</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">respiratory electron transport chain</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0044281</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">small molecule metabolic process</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0045333</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cellular respiration</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0048729</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">tissue morphogenesis</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005622</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>intracellular</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005737</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>cytoplasm</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005739</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>mitochondrion</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005743</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">mitochondrial inner membrane</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005746</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">mitochondrial respiratory chain</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005829</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>cytosol</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005856</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>cytoskeleton</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005912</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">adherens junction</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005916</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">fascia adherens</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0015629</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">actin cytoskeleton</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030016</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">myofibril</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030018</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">Z disc</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030027</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">lamellipodium</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030175</td>
<td align="center" colspan="1" rowspan="1">filopodium</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0031252</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cell leading edge</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0031674</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">I band</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0043229</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">intracellular organelle</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0042995</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>cell projection</bold>
</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0043234</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">protein complex</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0043292</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">contractile fibre</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0070161</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">anchoring junction</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0070469</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">respiratory chain</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0003678</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">DNA helicase activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0003774</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">motor activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0003824</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">catalytic activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0003954</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">NADH dehydrogenase activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0004386</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">helicase activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0008137</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">NADH dehydrogenase (ubiquinone) activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0015078</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">hydrogen ion transmembrane transporter activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016462</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">pyrophosphatase activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016491</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">oxidoreductase activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016817</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">hydrolase activity, acting on acid anhydrides</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016818</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0017111</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">nucleoside-triphosphatase activity</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0046873</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">metal ion transmembrane transporter activity</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p><sup>a)</sup> List of GOs related to human ASD from Chang <italic>et al</italic>. (2015).</p>
</fn>
<fn id="t002fn002">
<p><sup>b)</sup> List of GOs in the aged BTBR mouse model from Jasien <italic>et al</italic>. (2014). GOs were determined based on statistical significance (<italic>p</italic> &lt; 0.001). The <italic>p</italic>-value of each GO is shown in <xref ref-type="supplementary-material" rid="pone.0203543.s010">S8</xref> and <xref ref-type="supplementary-material" rid="pone.0203543.s011">S9</xref> Tables. GO enrichments from multiple studies are marked in bold.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>We found that VPA concentration dependently altered the number of ASD-related GOs (<xref ref-type="table" rid="pone.0203543.t003">Table 3</xref>). A total of 59 GOs were identified as ASD-related, including 25 GOs for the BP, 20 GOs for the CC, and 14 GOs for the MF. Synaptic transmission (GO: 0007268), transmission of nerve impulses (GO: 0019226), multicellular organismal signalling (GO: 0035637), and neurological system processes (GO: 0050877) were included in the BP category. Synapse-related GOs, i.e., synapses (GO: 0045202) and synapse parts (GO: 0044456), were in the CC category, and channel activity-related GOs, such as ion channel activity (GO: 0005216), cation channel activity (GO: 0005261), or ligand-gated ion channel activity (GO: 0015276), were found in the MF category.</p>
<table-wrap id="pone.0203543.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0203543.t003</object-id>
<label>Table 3</label>
<caption>
<title>GOs that exhibited significant concentration-dependent alterations among the ASD-related GOs suggested by previous studies.</title>
</caption>
<alternatives>
<graphic id="pone.0203543.t003g" xlink:href="pone.0203543.t003"></graphic>
<table frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" colspan="1" rowspan="2">Category</th>
<th align="center" colspan="1" rowspan="2">Chang <italic>et al</italic>. (2015)<xref ref-type="table-fn" rid="t003fn001"><sup>a)</sup></xref></th>
<th align="center" colspan="2" rowspan="1">Jasien <italic>et al</italic>. (2014)<xref ref-type="table-fn" rid="t003fn002"><sup>b)</sup></xref></th>
<th align="center" colspan="1" rowspan="2">Term</th>
<th align="center" colspan="1" rowspan="2"><italic>p</italic>-value</th>
</tr>
<tr>
<th align="center" colspan="1" rowspan="1">Cortical</th>
<th align="center" colspan="1" rowspan="1">Hippocampal</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0003001</bold>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0003001</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>generation of a signal involved in cell-cell signalling</bold>
</td>
<td align="center" colspan="1" rowspan="1">3.0e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0003008</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">system process</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.1e-11</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0006325</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">chromatin organization</td>
<td align="center" colspan="1" rowspan="1">2.3e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0006810</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>transport</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">9.5e-7</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0006836</td>
<td align="center" colspan="1" rowspan="1">neurotransmitter transport</td>
<td align="center" colspan="1" rowspan="1">6.2e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0006875</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cellular metal ion homeostasis</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">4.6e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0007187</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">sarcolemma</td>
<td align="center" colspan="1" rowspan="1">1.0e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0007188</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">adenylate cyclase-modulating G-protein coupled receptor signalling pathway</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.6e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0007267</td>
<td align="center" colspan="1" rowspan="1">cell-cell signalling</td>
<td align="center" colspan="1" rowspan="1">1.0e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0007268</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0007268</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>synaptic transmission</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">7.4e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0007613</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">memory</td>
<td align="center" colspan="1" rowspan="1">1.6e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016477</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cell migration</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">3.5e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="3" rowspan="1" style="background-color:#808080">
<bold>GO:0019226</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>transmission of nerve impulse</bold>
</td>
<td align="center" colspan="1" rowspan="1">4.1e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0023061</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">signal release</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">3.0e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030030</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">cell projection organization</td>
<td align="center" colspan="1" rowspan="1">5.0e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030705</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cytoskeleton-dependent intracellular transport</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">7.7e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030799</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">regulation of cyclic nucleotide metabolic process</td>
<td align="center" colspan="1" rowspan="1">3.1e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030802</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">regulation of cyclic nucleotide biosynthetic process</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.7e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030808</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">regulation of nucleotide biosynthetic process</td>
<td align="center" colspan="1" rowspan="1">2.7e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030814</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">regulation of cAMP metabolic process</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.4e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0030817</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">regulation of cAMP biosynthetic process</td>
<td align="center" colspan="1" rowspan="1">1.2e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0032940</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>secretion by cell</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.7e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0035637</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>multicellular organismal signalling</bold>
</td>
<td align="center" colspan="1" rowspan="1">2.2e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0040029</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">regulation of gene expression, epigenetic</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.8e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0044707</td>
<td align="center" colspan="1" rowspan="1">single-multicellular organism process</td>
<td align="center" colspan="1" rowspan="1">8.1e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0046903</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>secretion</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.3e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0048870</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">cell motility</td>
<td align="center" colspan="1" rowspan="1">1.6e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0050877</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>neurological system process</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">5.6e-13</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0051179</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">localization</td>
<td align="center" colspan="1" rowspan="1">1.2e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0051234</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>establishment of localization</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">4.8e-7</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0051674</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">localization of cell</td>
<td align="center" colspan="1" rowspan="1">1.6e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0055065</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">metal ion homeostasis</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">9.1e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0055082</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">cellular chemical homeostasis</td>
<td align="center" colspan="1" rowspan="1">2.9e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0065008</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">regulation of biological quality</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">4.6e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">BP</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0071944</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#FFFFFF"></td>
<td align="center" colspan="1" rowspan="1">cell periphery</td>
<td align="center" colspan="1" rowspan="1">2.6e-16</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0000785</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">chromatin</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.1e-7</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005623</td>
<td align="center" colspan="1" rowspan="1">cell</td>
<td align="center" colspan="1" rowspan="1">5.0e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005737</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>cytoplasm</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.3e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0005829</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>cytosol</bold>
</td>
<td align="center" colspan="1" rowspan="1">4.0e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005856</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cytoskeleton</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">4.9e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0016023</td>
<td align="center" colspan="1" rowspan="1">cytoplasmic membrane-bounded vesicle</td>
<td align="center" colspan="1" rowspan="1">1.4e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0031410</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cytoplasmic vesicle</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.0e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0031982</td>
<td align="center" colspan="1" rowspan="1">vesicle</td>
<td align="center" colspan="1" rowspan="1">9.1e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0031988</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">membrane-bounded vesicle</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">9.3e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0032991</td>
<td align="center" colspan="1" rowspan="1">macromolecular complex</td>
<td align="center" colspan="1" rowspan="1">3.2e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="3" rowspan="1" style="background-color:#808080">
<bold>GO:0042995</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>cell projection (at 72 h)</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">7.2e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="3" rowspan="1" style="background-color:#808080">
<bold>GO:0042995</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>cell projection (at 120 h)</bold>
</td>
<td align="center" colspan="1" rowspan="1">6.0e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0043226</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">organelle</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.8e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0043229</td>
<td align="center" colspan="1" rowspan="1">intracellular organelle</td>
<td align="center" colspan="1" rowspan="1">1.7e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="2" rowspan="1" style="background-color:#808080">
<bold>GO:0044444</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>cytoplasmic part</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">7.2e-7</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0044446</td>
<td align="center" colspan="1" rowspan="1">intracellular organelle part</td>
<td align="center" colspan="1" rowspan="1">4.9e-7</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0044456</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0044456</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">
<bold>synapse part</bold>
</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">2.7e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0045202</bold>
</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">
<bold>GO:0045202</bold>
</td>
<td align="center" colspan="1" rowspan="1">
<bold>synapse</bold>
</td>
<td align="center" colspan="1" rowspan="1">7.0e-7</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">CC</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0070161</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">anchoring junction</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.6e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">CC</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0070469</td>
<td align="center" colspan="1" rowspan="1">respiratory chain</td>
<td align="center" colspan="1" rowspan="1">2.7e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0003824</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">catalytic activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">4.1e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0004713</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">protein tyrosine kinase activity</td>
<td align="center" colspan="1" rowspan="1">6.3e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005216</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">ion channel activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">5.0e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005244</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">voltage-gated ion channel activity</td>
<td align="center" colspan="1" rowspan="1">3.2e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0005261</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">cation channel activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">6.9e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0015078</td>
<td align="center" colspan="1" rowspan="1">hydrogen ion transmembrane transporter activity</td>
<td align="center" colspan="1" rowspan="1">3.5e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0015276</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">ligand-gated ion channel activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">1.5e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0019905</td>
<td align="center" colspan="1" rowspan="1">syntaxin binding</td>
<td align="center" colspan="1" rowspan="1">1.6e-4</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0022832</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">voltage-gated channel activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">4.0e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0022834</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">ligand-gated channel activity</td>
<td align="center" colspan="1" rowspan="1">1.5e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0022836</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">gated channel activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">9.9e-6</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0022838</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">substrate-specific channel activity</td>
<td align="center" colspan="1" rowspan="1">5.8e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0022843</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9"></td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">voltage-gated cation channel activity</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#D9D9D9">5.7e-5</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1">MF</td>
<td align="center" colspan="1" rowspan="1" style="background-color:#808080">GO:0046873</td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">metal ion transmembrane transporter activity</td>
<td align="center" colspan="1" rowspan="1">1.0e-5</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p><sup>a)</sup> List of GOs related to human ASD from Chang <italic>et al</italic>. (2015).</p>
</fn>
<fn id="t003fn002">
<p><sup>b)</sup> List of GOs in the aged BTBR mouse model from Jasien <italic>et al</italic>. (2014). GO enrichments from multiple studies are marked in bold.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Discussion</title>
<sec id="sec018">
<title>Plausibility of zebrafish embryos/larvae as an ASD model based on transcriptome changes</title>
<p>We found a common transcriptional profile (DEGs and GOs) that was also found in previous ASD studies using human populations and mouse models. Thus, our transcriptome profile comparison data support the potential of zebrafish as an alternative animal model for ASD research. The zebrafish model has been proposed for ASD research based on behaviour phenotype [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0203543.ref033">33</xref>], and several ASD-related genes have been detected in the zebrafish [<xref ref-type="bibr" rid="pone.0203543.ref030">30</xref>]. However, this is the first comparison study to use transcriptome profiles. Our findings may be useful in the development of an alternative and rapid experimental model for screening ASD-related effects induced by environmental chemical exposure.</p>
<p>We observed 24 DEGs that had previously been suggested to be ASD-related genes in zebrafish embryos/larvae after VPA exposure (<xref ref-type="table" rid="pone.0203543.t001">Table 1</xref>). A total of 136 ASD-related genes, presented in <xref ref-type="supplementary-material" rid="pone.0203543.s005">S3</xref>–<xref ref-type="supplementary-material" rid="pone.0203543.s009">S7</xref> Tables, exhibited significant (<italic>p</italic> &lt; 0.05) or a 2-fold increase in expression (| log2FC | &gt; 1). These results indicate that zebrafish might, at least partly, have common genes and physiological pathways for ASD. The DEG (| log2FC | &gt; 1) commonalities in our study were as high as 36.4% (<xref ref-type="fig" rid="pone.0203543.g003">Fig 3</xref>). We believe that this is meaningful because the commonalities among the previous studies [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0203543.ref011">11</xref>] ranged from 6.3% to 60.6% (data were not shown). Additionally, commonalities with ASD were generally higher than those with other diseases (e.g., oral cancer or skin irritation), which would not expect an association with VPA exposure (<xref ref-type="supplementary-material" rid="pone.0203543.s002">S2(A) Fig</xref>) [<xref ref-type="bibr" rid="pone.0203543.ref043">43</xref>, <xref ref-type="bibr" rid="pone.0203543.ref044">44</xref>].</p>
<p>In our study, we found genes (<italic>adsl</italic>, <italic>mbd5</italic>, <italic>shank3a</italic>, and <italic>tsc1b</italic>) that had been reported to be ASD-related genes by multiple previous studies [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0203543.ref011">11</xref>]. The <italic>adsl</italic> gene is involved in the <italic>de novo</italic> purine biosynthesis pathway [<xref ref-type="bibr" rid="pone.0203543.ref045">45</xref>]. Previous studies reported that deficiency of the <italic>adsl</italic> gene might result in infantile seizures and autism [<xref ref-type="bibr" rid="pone.0203543.ref045">45</xref>, <xref ref-type="bibr" rid="pone.0203543.ref046">46</xref>, <xref ref-type="bibr" rid="pone.0203543.ref047">47</xref>]. Although the exact mechanisms are not yet clear, the possible mechanisms might include deficient synthesis of purine nucleotides, impairment of the purine nucleotide cycle, and a build-up of defective enzyme substrates [<xref ref-type="bibr" rid="pone.0203543.ref045">45</xref>]. The <italic>mbd5</italic> gene was thought to interact with myocyte enhancer factor 2c (MEF2C) in a complex bound to DNA [<xref ref-type="bibr" rid="pone.0203543.ref048">48</xref>]. Disruption of this complex due to <italic>mbd5</italic> mutation altered gene expression in neurogenesis and neurodevelopment [<xref ref-type="bibr" rid="pone.0203543.ref048">48</xref>]. In a cohort study, deletion of <italic>mbd5</italic> was also associated with autistic features [<xref ref-type="bibr" rid="pone.0203543.ref049">49</xref>]. The <italic>shank3</italic> gene, which encodes synaptic scaffolding protein, is important for spine morphogenesis and synaptic plasticity [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0203543.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0203543.ref032">32</xref>]. It might play a critical role in the normal development of neuronal connectivity because its disruption at a genetic level causes defects at striatal synapses and cortico-striatal circuits [<xref ref-type="bibr" rid="pone.0203543.ref050">50</xref>], as well as development and speech delays [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0203543.ref007">7</xref>], which might be associated with ASD. The <italic>tsc1</italic> gene is thought to be linked to ASD via perturbation of cytoskeletal dynamics and dendritic spine structure by inhibition of the mTOR signalling cascade, which plays a crucial role in synapse protein synthesis [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>]. Deletion of <italic>tsc1</italic> in mice elicited a loss of cerebellar Purkinje cells and produced ASD-like behaviour, including abnormal social interactions and repetitive behaviours [<xref ref-type="bibr" rid="pone.0203543.ref051">51</xref>]. In our qPCR analysis, transcriptions of those genes were significantly altered (<xref ref-type="fig" rid="pone.0203543.g004">Fig 4</xref>). VPA, a chemical that induces ASD, led to a significant increase in the transcription of <italic>adsl5</italic> and <italic>mbd5</italic> but a significant decrease in the transcription of <italic>shank3</italic> and <italic>tsc1b</italic> in our zebrafish embryo/larval model. These results were comparable with our results from RNA-seq analysis. As an exception, the direction of <italic>shank3a</italic> transcription was different. Among the exposed groups, however, the transcription pattern of <italic>shank3a</italic> was comparable. Despite the exception, the other results were considerably reliable.</p>
<p>Various genetic pathways, such as cell adhesion molecules, ion channels, scaffolding protein, cytoskeleton, and signalling pathways, are implicated in ASD [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>]. We found some of the genes included in those pathways (<italic>nrxn2</italic> (cell adhesion molecules), <italic>cacna1e</italic>, <italic>scn1a</italic> (ion channel), <italic>shank3</italic> (scaffolding protein), <italic>actn4</italic>, <italic>gria3</italic>, <italic>grid1</italic> (cytoskeleton), and <italic>eif4a</italic> (signalling pathway)) in our transcriptome analysis (<xref ref-type="supplementary-material" rid="pone.0203543.s005">S3</xref>–<xref ref-type="supplementary-material" rid="pone.0203543.s009">S7</xref> Tables). Moreover, ASD-related genes such as <italic>ak1</italic> (<italic>adenylate kinase 1</italic>) and <italic>ddb1</italic> (<italic>damage-specific DNA binding protein 1</italic>) were included in the top 100 DEGs that we found in the 50 μM VPA-exposed group, based on the <italic>p</italic>-value (<xref ref-type="supplementary-material" rid="pone.0203543.s012">S10</xref> and <xref ref-type="supplementary-material" rid="pone.0203543.s013">S11</xref> Tables). Our DEG results imply that zebrafish might possess similar ASD genetic pathways to humans and other animal models.</p>
<p>We found many of the common GO enrichments that are components of the ASD pathway [<xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0203543.ref040">40</xref>]. Specifically, we reported 44 and 69 significantly altered GOs based on the transcription changes compared with the control group (<xref ref-type="table" rid="pone.0203543.t002">Table 2</xref>) and concentration-dependent response (<xref ref-type="table" rid="pone.0203543.t003">Table 3</xref>), respectively. The commonality was up to 40.0% and 29.4%, respectively, based on the <italic>p</italic>-values (<italic>p</italic> &lt; 0.05 or <italic>p</italic> &lt; 0.001). Those values were higher than the commonality with other diseases, i.e., oral cancer (8.7% and 1.0%, respectively) or dermatological disorder (19.2% and 1.9%, respectively) (<xref ref-type="supplementary-material" rid="pone.0203543.s002">S2(B) Fig</xref>) [<xref ref-type="bibr" rid="pone.0203543.ref052">52</xref>]. These comparison data of GO enrichments may support the idea that zebrafish, at least partly, share common physiology for ASD with other models.</p>
<p>We showed higher commonality with ASD than with other diseases, especially in the GO enrichment comparisons with stringent <italic>p</italic>-values (<italic>p</italic> &lt; 0.001) (<xref ref-type="supplementary-material" rid="pone.0203543.s002">S2 Fig</xref>). However, commonality was relatively low in the DEG comparison. These results might be because GO enrichments represent a comprehensive approach. This implies that GO enrichments might adjust the bias from the transcriptions of certain genes. However, the results in <xref ref-type="supplementary-material" rid="pone.0203543.s002">S2 Fig</xref> are shown by a simple comparison among the respective lists of DEGs and GO enrichments, which could be due to methodological limitations. However, commonalities with other diseases, i.e., oral cancer or dermatological disorder, were observed in our study, although those were relatively weak. This might be expected because alterations of such basic pathways, such as the cytoskeleton or cell division, are also relevant to oral cancer or dermatological disorders [<xref ref-type="bibr" rid="pone.0203543.ref044">44</xref>, <xref ref-type="bibr" rid="pone.0203543.ref052">52</xref>]. In addition, VPA is known to have the potential to cause other side effects, such as hepatotoxicity and metabolic derangements, as well as VPA being an ASD inducer [<xref ref-type="bibr" rid="pone.0203543.ref053">53</xref>].</p>
<p>Among the significantly affected GOs, GOs involved in the cellular component pathway were abundant (<xref ref-type="table" rid="pone.0203543.t002">Table 2</xref>). The presence of GO enrichments related to mitochondria (<italic>mitochondrion</italic> (GO: 0005739), <italic>mitochondrial inner membrane</italic> (GO: 0005743), and <italic>mitochondrial respiratory chain</italic> (GO: 0005746)) and the cytoskeleton (<italic>cytoskeleton</italic> (GO: 0005856) and <italic>actin cytoskeleton</italic> (GO: 0015629)) were significant (<italic>p</italic> &lt; 0.001) (<xref ref-type="table" rid="pone.0203543.t002">Table 2</xref>). Recent studies have indicated that mitochondria dysfunction augments and disseminates brain abnormalities related to ASD [<xref ref-type="bibr" rid="pone.0203543.ref054">54</xref>, <xref ref-type="bibr" rid="pone.0203543.ref055">55</xref>]. Interestingly, a significant proportion of ASD patients have concomitant diseases related to mitochondrial disease and abnormal energy generation [<xref ref-type="bibr" rid="pone.0203543.ref056">56</xref>]. The cytoskeleton is also important for the positioning of cell adhesion molecules and neurotransmitter receptors at the synapse [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>] and is essential for maintaining synaptic function [<xref ref-type="bibr" rid="pone.0203543.ref014">14</xref>]. The <italic>tsc1</italic> gene, which we found to be significantly transcribed in our study, is related to the cytoskeleton pathway in ASD [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>]. In addition, a previous study found neuronal signalling/cytoskeleton pathways containing <italic>actin cytoskeleton</italic> (GO: 0015629), <italic>actin cytoskeleton organization</italic> (GO: 0015629), and others to be major pathways of VPA-induced GOs in zebrafish when compared using the human functional network analysis [<xref ref-type="bibr" rid="pone.0203543.ref006">6</xref>] (<xref ref-type="supplementary-material" rid="pone.0203543.s010">S8 Table</xref>).</p>
<p>We found that significantly affected GOs were extended in a concentration-dependent manner (<xref ref-type="table" rid="pone.0203543.t003">Table 3</xref>). We observed GO enrichments closer to the direct ASD pathway in VPA-exposed zebrafish. GOs in the nervous system, e.g., <italic>synaptic transmission</italic> (GO: 0007268), <italic>transmission of nerve impulse</italic> (GO: 0019226), and <italic>neurological system process</italic> (GO: 0050877), were involved. Additionally, GO enrichments of synapses (<italic>synapse part</italic> (GO: 0044456) and <italic>synapse</italic> (GO: 0045202)) for which dysfunction is crucial for ASD were significant [<xref ref-type="bibr" rid="pone.0203543.ref002">2</xref>]. Furthermore, many of the ion channel-related GOs, which play an important role in the aetiology of ASD by enhancing neuronal excitability [<xref ref-type="bibr" rid="pone.0203543.ref001">1</xref>], were also significant, e.g., <italic>ion channel activity</italic> (GO: 0005216), <italic>cation channel activity</italic> (GO: 0005261), and <italic>ligand-gated channel activity</italic> (GO: 0022834). These significant changes observed in GOs in our study imply that zebrafish, at least partly, share commonalties with humans or mice with respect to ASD aetiology. This might indicate that zebrafish could be applicable to ASD research, e.g., ASD-inducing environmental chemical screening or ASD drug discovery.</p>
</sec>
<sec id="sec019">
<title>Plausibility of zebrafish embryos/larvae as an ASD model based on behavioural changes</title>
<p>In addition to changes in gene transcription, the development of an experimental animal model for ASD requires strategies for behavioural observation. This is important because the symptoms of ASD are generally defined by behavioural characteristics, i.e., impaired social communication, repetitive behaviour, and cognitive deficits [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>]. Previous studies have examined locomotor activity and social interaction behaviour in a transgenic monkey model [<xref ref-type="bibr" rid="pone.0203543.ref012">12</xref>]. Similar behavioural tests, such as social preference tests, the partition test, and the reciprocal social interaction test, have also been applied to rodent models [<xref ref-type="bibr" rid="pone.0203543.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0203543.ref057">57</xref>]. Stewart et al. [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>] compared measurable behavioural endpoints in rodent and zebrafish models and suggested a number of behavioural testing methods that could be applied to adult zebrafish. These included the social preference test, social interaction test, shoaling assessment, mirror stimulation test, and stereotypic circling and swimming [<xref ref-type="bibr" rid="pone.0203543.ref025">25</xref>]. However, adult zebrafish are not as effective as embryos for screening the ASD-like effects of many kinds of chemicals. The test tools for social behaviour in the zebrafish larvae stage have not yet been completely developed. Therefore, instead of social behaviour, locomotor activity and anxiety have been used as markers of the ASD phenotype in ASD toxicity tests involving zebrafish embryos [<xref ref-type="bibr" rid="pone.0203543.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0203543.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0203543.ref058">58</xref>]. Thus, in the present study, we analysed locomotor activity in zebrafish larvae after VPA exposure as a behavioural endpoint.</p>
<p>We found that locomotor activity, i.e., the total distance moved and active duration, significantly decreased after exposure to 50 μM VPA (<xref ref-type="fig" rid="pone.0203543.g002">Fig 2</xref>). Previous studies reported similar levels of hypoactivity [<xref ref-type="bibr" rid="pone.0203543.ref031">31</xref>]. However, these effects, observed in both the current and previous studies, might be related to a VPA-induced delay in zebrafish hatching (<xref ref-type="fig" rid="pone.0203543.g001">Fig 1</xref>). We found that locomotor activity in zebrafish larvae slightly increased following exposure to 25 μM VPA. This was in accordance with a previous study and might indicate that VPA exposure causes anxiety in zebrafish larvae [<xref ref-type="bibr" rid="pone.0203543.ref034">34</xref>]. In a previous study, VPA exposure caused anxiety in larval zebrafish and resulted in social interaction deficits in adults [<xref ref-type="bibr" rid="pone.0203543.ref034">34</xref>]. Therefore, the observed effects on locomotor activity at the larval stage in our study could be linked to ASD-like behaviour. Although locomotor activity alone is not sufficient as a model of ASD in zebrafish larvae, this may be an important step, as such locomotor changes could reflect changes in basal activity elicited by ASD in terms of transcriptional alteration.</p>
</sec>
<sec id="sec020">
<title>Further research regarding the use of zebrafish as an ASD experimental model</title>
<p>In the present study, we used transcriptome analysis and behaviour observation to show that the zebrafish embryo/larva has potential as an alternative animal model for ASD research. However, further studies are required. First, multiple chemicals used in ASD models, known as inducers, should be examined in the zebrafish embryo/larvae model. It is necessary to confirm that the zebrafish embryo/larvae model responds appropriately when other types of ASD inducers are used. Second, genes that are common to multiple ASD models and those that are particularly sensitive to environmental exposure should be determined. This genetic information may be useful in developing transgenic zebrafish models for screening the ASD-like effects of environmental chemicals and new drug candidates for ASD. Third, tools for appropriate behavioural examination should be optimized for the zebrafish embryos/larvae model, including, for instance, those that involve locomotor analysis.</p>
</sec>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Conclusion</title>
<p>In this study, we evaluated the plausibility of zebrafish embryos/larvae as an alternative animal model for ASD research. To this end, we exposed zebrafish embryos/larvae to VPA, examined the subsequent developmental and behavioural changes, and analysed transcriptional alterations by RNA-seq. We found behavioural and transcriptional changes that matched those from previous ASD studies using humans and rodent models. The results of this preliminary study indicate that the zebrafish embryo/larva has potential as an alternative experimental animal model for ASD toxicity tests and ASD drug discovery.</p>
</sec>
<sec id="sec022" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="pone.0203543.s001">
<label>S1 Fig</label>
<caption>
<title>Differentially expressed genes (DEGs) after exposure to VPA for 72 h and 120 h.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s001.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s002">
<label>S2 Fig</label>
<caption>
<p>Comparison of commonalities of (a) DEGs and (b) GOs between ASD (shown in <xref ref-type="fig" rid="pone.0203543.g003">Fig 3</xref>) and other oral and skin-related diseases.</p>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s002.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s003">
<label>S1 Table</label>
<caption>
<title>Primer sequences for qRT-PCR analysis used in this study.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s003.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s004">
<label>S2 Table</label>
<caption>
<title>Statistics for read mapping.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s004.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s005">
<label>S3 Table</label>
<caption>
<title>Differentially expressed genes after VPA exposure in zebrafish embryos/larvae among the ASD-related genes suggested by Voineagu <italic>et al</italic>. (2011).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s005.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s006">
<label>S4 Table</label>
<caption>
<title>Differentially expressed genes after VPA exposure in zebrafish embryos/larvae among the ASD-related genes suggested by Pinto <italic>et al</italic>. (2014).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s006.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s007">
<label>S5 Table</label>
<caption>
<title>Differentially expressed genes after VPA exposure in zebrafish embryos/larvae among the ASD-related genes suggested by Sanders <italic>et al</italic>. (2015).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s007.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s008">
<label>S6 Table</label>
<caption>
<title>Differentially expressed genes after VPA exposure in zebrafish embryos/larvae among the ASD-related genes suggested by Bourgeron <italic>et al</italic>. (2014).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s008.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s009">
<label>S7 Table</label>
<caption>
<title>Differentially expressed genes after VPA exposure in zebrafish embryos/larvae among the ASD-related genes suggested by Chang <italic>et al</italic>. (2014).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s009.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s010">
<label>S8 Table</label>
<caption>
<title>Significantly affected GO after VPA exposure in zebrafish embryos/larvae among the ASD-related GO suggested by Chang <italic>et al</italic>. (2014).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s010.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s011">
<label>S9 Table</label>
<caption>
<title>Significantly affected GO after VPA exposure in zebrafish embryos/larvae among the ASD-related GOs in the BTBR mouse model suggested by Jasien <italic>et al</italic>. (2014).</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s011.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s012">
<label>S10 Table</label>
<caption>
<title>The top 100 DEGs after 50 μM VPA exposure at 72 h based on <italic>p</italic>-value.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s012.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0203543.s013">
<label>S11 Table</label>
<caption>
<title>The top 100 DEGs after 50 μM VPA exposure at 120 h based on <italic>p</italic>-value.</title>
<p>(DOCX)</p>
</caption>
<media xlink:href="pone.0203543.s013.docx">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0203543.ref001">
<label>1</label>
<mixed-citation publication-type="journal"><name><surname>Banerjee</surname><given-names>S</given-names></name>, <name><surname>Riordan</surname><given-names>M</given-names></name>, <name><surname>Bhat</surname><given-names>MA</given-names></name>. <article-title>Genetic aspects of autism spectrum disorders: insights from animal models</article-title>. <source/>Front Cell Neurosci. <year>2014</year>;<volume>8</volume>:<fpage>58</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00058</pub-id> ; PubMed Central PMCID: PMCPMC3932417.<pub-id pub-id-type="pmid">24605088</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref002">
<label>2</label>
<mixed-citation publication-type="journal"><name><surname>Bourgeron</surname><given-names>T</given-names></name>. <article-title>From the genetic architecture to synaptic plasticity in autism spectrum disorder</article-title>. <source/>Nat Rev Neurosci. <year>2015</year>;<volume>16</volume>(<issue>9</issue>):<fpage>551</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3992</pub-id> .<pub-id pub-id-type="pmid">26289574</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref003">
<label>3</label>
<mixed-citation publication-type="journal"><name><surname>Idring</surname><given-names>S</given-names></name>, <name><surname>Lundberg</surname><given-names>M</given-names></name>, <name><surname>Sturm</surname><given-names>H</given-names></name>, <name><surname>Dalman</surname><given-names>C</given-names></name>, <name><surname>Gumpert</surname><given-names>C</given-names></name>, <name><surname>Rai</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Changes in Prevalence of Autism Spectrum Disorders in 2001–2011: Findings from the Stockholm Youth Cohort</article-title>. <source/>Journal of Autism and Developmental Disorders. <year>2015</year>;<volume>45</volume>(<issue>6</issue>):<fpage>1766</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-014-2336-y</pub-id>
<pub-id pub-id-type="pmid">25475364</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref004">
<label>4</label>
<mixed-citation publication-type="other">Christensen D, Baio J, Braun K. Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. 2016.</mixed-citation>
</ref>
<ref id="pone.0203543.ref005">
<label>5</label>
<mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>YS</given-names></name>, <name><surname>Leventhal</surname><given-names>BL</given-names></name>, <name><surname>Koh</surname><given-names>YJ</given-names></name>, <name><surname>Fombonne</surname><given-names>E</given-names></name>, <name><surname>Laska</surname><given-names>E</given-names></name>, <name><surname>Lim</surname><given-names>EC</given-names></name>, <etal>et al</etal>
<article-title>Prevalence of Autism Spectrum Disorders in a Total Population Sample</article-title>. <source/>American Journal of Psychiatry. <year>2011</year>;<volume>168</volume>(<issue>9</issue>):<fpage>904</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101532</pub-id> .<pub-id pub-id-type="pmid">21558103</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref006">
<label>6</label>
<mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>J</given-names></name>, <name><surname>Gilman</surname><given-names>SR</given-names></name>, <name><surname>Chiang</surname><given-names>AH</given-names></name>, <name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>Vitkup</surname><given-names>D</given-names></name>. <article-title>Genotype to phenotype relationships in autism spectrum disorders</article-title>. <source/>Nat Neurosci. <year>2015</year>;<volume>18</volume>(<issue>2</issue>):<fpage>191</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3907</pub-id> ; PubMed Central PMCID: PMCPMC4397214.<pub-id pub-id-type="pmid">25531569</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref007">
<label>7</label>
<mixed-citation publication-type="journal"><name><surname>Durand</surname><given-names>CM</given-names></name>, <name><surname>Betancur</surname><given-names>C</given-names></name>, <name><surname>Boeckers</surname><given-names>TM</given-names></name>, <name><surname>Bockmann</surname><given-names>J</given-names></name>, <name><surname>Chaste</surname><given-names>P</given-names></name>, <name><surname>Fauchereau</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders</article-title>. <source/>Nat Genet. <year>2007</year>;<volume>39</volume>(<issue>1</issue>):<fpage>25</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/ng1933</pub-id> ; PubMed Central PMCID: PMCPMC2082049.<pub-id pub-id-type="pmid">17173049</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref008">
<label>8</label>
<mixed-citation publication-type="journal"><name><surname>Gkogkas</surname><given-names>CG</given-names></name>, <name><surname>Khoutorsky</surname><given-names>A</given-names></name>, <name><surname>Ran</surname><given-names>I</given-names></name>, <name><surname>Rampakakis</surname><given-names>E</given-names></name>, <name><surname>Nevarko</surname><given-names>T</given-names></name>, <name><surname>Weatherill</surname><given-names>DB</given-names></name>, <etal>et al</etal>
<article-title>Autism-related deficits via dysregulated eIF4E-dependent translational control</article-title>. <source/>Nature. <year>2013</year>;<volume>493</volume>(<issue>7432</issue>):<fpage>371</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nature11628</pub-id> ; PubMed Central PMCID: PMCPMC4133997.<pub-id pub-id-type="pmid">23172145</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref009">
<label>9</label>
<mixed-citation publication-type="journal"><name><surname>Pinto</surname><given-names>D</given-names></name>, <name><surname>Delaby</surname><given-names>E</given-names></name>, <name><surname>Merico</surname><given-names>D</given-names></name>, <name><surname>Barbosa</surname><given-names>M</given-names></name>, <name><surname>Merikangas</surname><given-names>A</given-names></name>, <name><surname>Klei</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Convergence of genes and cellular pathways dysregulated in autism spectrum disorders</article-title>. <source/>Am J Hum Genet. <year>2014</year>;<volume>94</volume>(<issue>5</issue>):<fpage>677</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.03.018</pub-id> ; PubMed Central PMCID: PMCPMC4067558.<pub-id pub-id-type="pmid">24768552</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref010">
<label>10</label>
<mixed-citation publication-type="journal"><name><surname>State</surname><given-names>MW</given-names></name>, <name><surname>Sestan</surname><given-names>N</given-names></name>. <article-title>Neuroscience. The emerging biology of autism spectrum disorders</article-title>. <source/>Science. <year>2012</year>;<volume>337</volume>(<issue>6100</issue>):<fpage>1301</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1126/science.1224989</pub-id> ; PubMed Central PMCID: PMCPMC3657753.<pub-id pub-id-type="pmid">22984058</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref011">
<label>11</label>
<mixed-citation publication-type="journal"><name><surname>Voineagu</surname><given-names>I</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Johnston</surname><given-names>P</given-names></name>, <name><surname>Lowe</surname><given-names>JK</given-names></name>, <name><surname>Tian</surname><given-names>Y</given-names></name>, <name><surname>Horvath</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology</article-title>. <source/>Nature. <year>2011</year>;<volume>474</volume>(<issue>7351</issue>):<fpage>380</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/nature10110</pub-id> ; PubMed Central PMCID: PMCPMC3607626.<pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref012">
<label>12</label>
<mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Zhang</surname><given-names>JT</given-names></name>, <name><surname>Cai</surname><given-names>YJ</given-names></name>, <name><surname>Cheng</surname><given-names>TL</given-names></name>, <name><surname>Cheng</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2</article-title>. <source/>Nature. <year>2016</year>;<volume>530</volume>(<issue>7588</issue>):<fpage>98</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1038/nature16533</pub-id> .<pub-id pub-id-type="pmid">26808898</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref013">
<label>13</label>
<mixed-citation publication-type="journal"><name><surname>Mathur</surname><given-names>P</given-names></name>, <name><surname>Guo</surname><given-names>S</given-names></name>. <article-title>Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes</article-title>. <source/>Neurobiol Dis. <year>2010</year>;<volume>40</volume>(<issue>1</issue>):<fpage>66</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.05.016</pub-id> ; PubMed Central PMCID: PMCPMC3021971.<pub-id pub-id-type="pmid">20493262</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref014">
<label>14</label>
<mixed-citation publication-type="journal"><name><surname>Yoo</surname><given-names>H</given-names></name>. <article-title>Genetics of Autism Spectrum Disorder: Current Status and Possible Clinical Applications</article-title>. <source/>Exp Neurobiol. <year>2015</year>;<volume>24</volume>(<issue>4</issue>):<fpage>257</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.5607/en.2015.24.4.257</pub-id> ; PubMed Central PMCID: PMCPMC4688327.<pub-id pub-id-type="pmid">26713075</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref015">
<label>15</label>
<mixed-citation publication-type="journal"><name><surname>Weintraub</surname><given-names>K</given-names></name>. <article-title>The prevalence puzzle: Autism counts</article-title>. <source/>Nature. <year>2011</year>;<volume>479</volume>(<issue>7371</issue>):<fpage>22</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/479022a</pub-id> .<pub-id pub-id-type="pmid">22051656</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref016">
<label>16</label>
<mixed-citation publication-type="journal"><name><surname>Becerra</surname><given-names>TA</given-names></name>, <name><surname>Wilhelm</surname><given-names>M</given-names></name>, <name><surname>Olsen</surname><given-names>J</given-names></name>, <name><surname>Cockburn</surname><given-names>M</given-names></name>, <name><surname>Ritz</surname><given-names>B</given-names></name>. <article-title>Ambient air pollution and autism in Los Angeles county, California</article-title>. <source/>Environ Health Perspect. <year>2013</year>;<volume>121</volume>(<issue>3</issue>):<fpage>380</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1205827</pub-id> ; PubMed Central PMCID: PMCPMC3621187.<pub-id pub-id-type="pmid">23249813</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref017">
<label>17</label>
<mixed-citation publication-type="journal"><name><surname>Braun</surname><given-names>JM</given-names></name>, <name><surname>Kalkbrenner</surname><given-names>AE</given-names></name>, <name><surname>Just</surname><given-names>AC</given-names></name>, <name><surname>Yolton</surname><given-names>K</given-names></name>, <name><surname>Calafat</surname><given-names>AM</given-names></name>, <name><surname>Sjodin</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study</article-title>. <source/>Environ Health Perspect. <year>2014</year>;<volume>122</volume>(<issue>5</issue>):<fpage>513</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1307261</pub-id> ; PubMed Central PMCID: PMCPMC4014765.<pub-id pub-id-type="pmid">24622245</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref018">
<label>18</label>
<mixed-citation publication-type="journal"><name><surname>Dickerson</surname><given-names>AS</given-names></name>, <name><surname>Rahbar</surname><given-names>MH</given-names></name>, <name><surname>Han</surname><given-names>I</given-names></name>, <name><surname>Bakian</surname><given-names>AV</given-names></name>, <name><surname>Bilder</surname><given-names>DA</given-names></name>, <name><surname>Harrington</surname><given-names>RA</given-names></name>, <etal>et al</etal>
<article-title>Autism spectrum disorder prevalence and proximity to industrial facilities releasing arsenic, lead or mercury</article-title>. <source/>Sci Total Environ. <year>2015</year>;<volume>536</volume>:<fpage>245</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2015.07.024</pub-id> ; PubMed Central PMCID: PMCPMC4721249.<pub-id pub-id-type="pmid">26218563</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref019">
<label>19</label>
<mixed-citation publication-type="journal"><name><surname>Kalkbrenner</surname><given-names>AE</given-names></name>, <name><surname>Schmidt</surname><given-names>RJ</given-names></name>, <name><surname>Penlesky</surname><given-names>AC</given-names></name>. <article-title>Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence</article-title>. <source/>Curr Probl Pediatr Adolesc Health Care. <year>2014</year>;<volume>44</volume>(<issue>10</issue>):<fpage>277</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.cppeds.2014.06.001</pub-id> ; PubMed Central PMCID: PMCPMC4855851.<pub-id pub-id-type="pmid">25199954</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref020">
<label>20</label>
<mixed-citation publication-type="journal"><name><surname>Raz</surname><given-names>R</given-names></name>, <name><surname>Roberts</surname><given-names>AL</given-names></name>, <name><surname>Lyall</surname><given-names>K</given-names></name>, <name><surname>Hart</surname><given-names>JE</given-names></name>, <name><surname>Just</surname><given-names>AC</given-names></name>, <name><surname>Laden</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case-control analysis within the Nurses' Health Study II Cohort</article-title>. <source/>Environ Health Perspect. <year>2015</year>;<volume>123</volume>(<issue>3</issue>):<fpage>264</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1408133</pub-id> ; PubMed Central PMCID: PMCPMC4348742.<pub-id pub-id-type="pmid">25522338</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref021">
<label>21</label>
<mixed-citation publication-type="journal"><name><surname>Shelton</surname><given-names>JF</given-names></name>, <name><surname>Hertz-Picciotto</surname><given-names>I</given-names></name>, <name><surname>Pessah</surname><given-names>IN</given-names></name>. <article-title>Tipping the balance of autism risk: potential mechanisms linking pesticides and autism</article-title>. <source/>Environ Health Perspect. <year>2012</year>;<volume>120</volume>(<issue>7</issue>):<fpage>944</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1104553</pub-id> ; PubMed Central PMCID: PMCPMC3404662.<pub-id pub-id-type="pmid">22534084</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref022">
<label>22</label>
<mixed-citation publication-type="journal"><name><surname>Rossignol</surname><given-names>DA</given-names></name>, <name><surname>Genuis</surname><given-names>SJ</given-names></name>, <name><surname>Frye</surname><given-names>RE</given-names></name>. <article-title>Environmental toxicants and autism spectrum disorders: a systematic review</article-title>. <source/>Transl Psychiatry. <year>2014</year>;<volume>4</volume>:<fpage>e360</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.4</pub-id> ; PubMed Central PMCID: PMCPMC3944636.<pub-id pub-id-type="pmid">24518398</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref023">
<label>23</label>
<mixed-citation publication-type="journal"><name><surname>Shelton</surname><given-names>JF</given-names></name>, <name><surname>Geraghty</surname><given-names>EM</given-names></name>, <name><surname>Tancredi</surname><given-names>DJ</given-names></name>, <name><surname>Delwiche</surname><given-names>LD</given-names></name>, <name><surname>Schmidt</surname><given-names>RJ</given-names></name>, <name><surname>Ritz</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: the CHARGE study</article-title>. <source/>Environ Health Perspect. <year>2014</year>;<volume>122</volume>(<issue>10</issue>):<fpage>1103</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1289/ehp.1307044</pub-id> ; PubMed Central PMCID: PMCPMC4181917.<pub-id pub-id-type="pmid">24954055</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref024">
<label>24</label>
<mixed-citation publication-type="journal"><name><surname>Landrigan</surname><given-names>PJ</given-names></name>. <article-title>What causes autism? Exploring the environmental contribution</article-title>. <source/>Curr Opin Pediatr. <year>2010</year>;<volume>22</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1097/MOP.0b013e328336eb9a</pub-id> .<pub-id pub-id-type="pmid">20087185</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref025">
<label>25</label>
<mixed-citation publication-type="journal"><name><surname>Stewart</surname><given-names>AM</given-names></name>, <name><surname>Nguyen</surname><given-names>M</given-names></name>, <name><surname>Wong</surname><given-names>K</given-names></name>, <name><surname>Poudel</surname><given-names>MK</given-names></name>, <name><surname>Kalueff</surname><given-names>AV</given-names></name>. <article-title>Developing zebrafish models of autism spectrum disorder (ASD)</article-title>. <source/>Prog Neuropsychopharmacol Biol Psychiatry. <year>2014</year>;<volume>50</volume>:<fpage>27</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.11.014</pub-id> .<pub-id pub-id-type="pmid">24315837</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref026">
<label>26</label>
<mixed-citation publication-type="journal"><name><surname>Kurian</surname><given-names>JR</given-names></name>, <name><surname>Forbes-Lorman</surname><given-names>RM</given-names></name>, <name><surname>Auger</surname><given-names>AP</given-names></name>. <article-title>Sex Difference in Mecp2 Expression During a Critical Period of Rat Brain Development</article-title>. <source/>Epigenetics. <year>2007</year>;<volume>2</volume>(<issue>3</issue>):<fpage>173</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4161/epi.2.3.4841</pub-id>
<pub-id pub-id-type="pmid">17965589</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref027">
<label>27</label>
<mixed-citation publication-type="journal"><name><surname>Silverman</surname><given-names>JL</given-names></name>, <name><surname>Yang</surname><given-names>M</given-names></name>, <name><surname>Lord</surname><given-names>C</given-names></name>, <name><surname>Crawley</surname><given-names>JN</given-names></name>. <article-title>Behavioural phenotyping assays for mouse models of autism</article-title>. <source/>Nat Rev Neurosci. <year>2010</year>;<volume>11</volume>(<issue>7</issue>):<fpage>490</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2851</pub-id> ; PubMed Central PMCID: PMCPMC3087436.<pub-id pub-id-type="pmid">20559336</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref028">
<label>28</label>
<mixed-citation publication-type="journal"><name><surname>Kalueff</surname><given-names>AV</given-names></name>, <name><surname>Stewart</surname><given-names>AM</given-names></name>, <name><surname>Gerlai</surname><given-names>R</given-names></name>. <article-title>Zebrafish as an emerging model for studying complex brain disorders</article-title>. <source/>Trends Pharmacol Sci. <year>2014</year>;<volume>35</volume>(<issue>2</issue>):<fpage>63</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2013.12.002</pub-id> ; PubMed Central PMCID: PMCPMC3913794.<pub-id pub-id-type="pmid">24412421</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref029">
<label>29</label>
<mixed-citation publication-type="journal"><name><surname>Hill</surname><given-names>AJ</given-names></name>, <name><surname>Teraoka</surname><given-names>H</given-names></name>, <name><surname>Heideman</surname><given-names>W</given-names></name>, <name><surname>Peterson</surname><given-names>RE</given-names></name>. <article-title>Zebrafish as a model vertebrate for investigating chemical toxicity</article-title>. <source/>Toxicol Sci. <year>2005</year>;<volume>86</volume>(<issue>1</issue>):<fpage>6</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1093/toxsci/kfi110</pub-id> .<pub-id pub-id-type="pmid">15703261</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref030">
<label>30</label>
<mixed-citation publication-type="journal"><name><surname>Tropepe</surname><given-names>V</given-names></name>, <name><surname>Sive</surname><given-names>HL</given-names></name>. <article-title>Can zebrafish be used as a model to study the neurodevelopmental causes of autism?</article-title>
<source/>Genes, Brain and Behavior. <year>2003</year>;<volume>2</volume>(<issue>5</issue>):<fpage>268</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00038.x</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref031">
<label>31</label>
<mixed-citation publication-type="journal"><name><surname>Bailey</surname><given-names>JM</given-names></name>, <name><surname>Oliveri</surname><given-names>AN</given-names></name>, <name><surname>Karbhari</surname><given-names>N</given-names></name>, <name><surname>Brooks</surname><given-names>RA</given-names></name>, <name><surname>De La Rocha</surname><given-names>AJ</given-names></name>, <name><surname>Janardhan</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Persistent behavioral effects following early life exposure to retinoic acid or valproic acid in zebrafish</article-title>. <source/>Neurotoxicology. <year>2016</year>;<volume>52</volume>:<fpage>23</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuro.2015.10.001</pub-id> ; PubMed Central PMCID: PMCPMC4753107.<pub-id pub-id-type="pmid">26439099</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref032">
<label>32</label>
<mixed-citation publication-type="journal"><name><surname>Kozol</surname><given-names>RA</given-names></name>, <name><surname>Cukier</surname><given-names>HN</given-names></name>, <name><surname>Zou</surname><given-names>B</given-names></name>, <name><surname>Mayo</surname><given-names>V</given-names></name>, <name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>Cai</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Two knockdown models of the autism genes SYNGAP1 and SHANK3 in zebrafish produce similar behavioral phenotypes associated with embryonic disruptions of brain morphogenesis</article-title>. <source/>Hum Mol Genet. <year>2015</year>;<volume>24</volume>(<issue>14</issue>):<fpage>4006</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv138</pub-id> ; PubMed Central PMCID: PMCPMC4476447.<pub-id pub-id-type="pmid">25882707</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref033">
<label>33</label>
<mixed-citation publication-type="journal"><name><surname>Maaswinkel</surname><given-names>H</given-names></name>, <name><surname>Zhu</surname><given-names>L</given-names></name>, <name><surname>Weng</surname><given-names>W</given-names></name>. <article-title>Assessing social engagement in heterogeneous groups of zebrafish: a new paradigm for autism-like behavioral responses</article-title>. <source/>PLoS One. <year>2013</year>;<volume>8</volume>(<issue>10</issue>):<fpage>e75955</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0075955</pub-id> ; PubMed Central PMCID: PMCPMC3792997.<pub-id pub-id-type="pmid">24116082</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref034">
<label>34</label>
<mixed-citation publication-type="journal"><name><surname>Zimmermann</surname><given-names>FF</given-names></name>, <name><surname>Gaspary</surname><given-names>KV</given-names></name>, <name><surname>Leite</surname><given-names>CE</given-names></name>, <name><surname>De Paula Cognato</surname><given-names>G</given-names></name>, <name><surname>Bonan</surname><given-names>CD</given-names></name>. <article-title>Embryological exposure to valproic acid induces social interaction deficits in zebrafish (<italic>Danio rerio</italic>): A developmental behavior analysis</article-title>. <source/>Neurotoxicol Teratol. <year>2015</year>;<volume>52</volume>(<issue>Pt A</issue>):<fpage>36</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.ntt.2015.10.002</pub-id> .<pub-id pub-id-type="pmid">26477937</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref035">
<label>35</label>
<mixed-citation publication-type="journal"><name><surname>Dobin</surname><given-names>A</given-names></name>, <name><surname>Davis</surname><given-names>CA</given-names></name>, <name><surname>Schlesinger</surname><given-names>F</given-names></name>, <name><surname>Drenkow</surname><given-names>J</given-names></name>, <name><surname>Zaleski</surname><given-names>C</given-names></name>, <name><surname>Jha</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source/>Bioinformatics. <year>2013</year>;<volume>29</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref036">
<label>36</label>
<mixed-citation publication-type="journal"><name><surname>Trapnell</surname><given-names>C</given-names></name>, <name><surname>Pachter</surname><given-names>L</given-names></name>, <name><surname>Salzberg</surname><given-names>SL</given-names></name>. <article-title>TopHat: discovering splice junctions with RNA-Seq</article-title>. <source/>Bioinformatics. <year>2009</year>;<volume>25</volume>(<issue>9</issue>):<fpage>1105</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp120</pub-id>
<pub-id pub-id-type="pmid">19289445</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref037">
<label>37</label>
<mixed-citation publication-type="journal"><name><surname>Anders</surname><given-names>S</given-names></name>, <name><surname>Pyl</surname><given-names>PT</given-names></name>, <name><surname>Huber</surname><given-names>W</given-names></name>. <article-title>HTSeq—a Python framework to work with high-throughput sequencing data</article-title>. <source/>Bioinformatics. <year>2015</year>;<volume>31</volume>(<issue>2</issue>):<fpage>166</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id>
<pub-id pub-id-type="pmid">25260700</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref038">
<label>38</label>
<mixed-citation publication-type="journal"><name><surname>Sun</surname><given-names>J</given-names></name>, <name><surname>Nishiyama</surname><given-names>T</given-names></name>, <name><surname>Shimizu</surname><given-names>K</given-names></name>, <name><surname>Kadota</surname><given-names>K</given-names></name>. <article-title>TCC: an R package for comparing tag count data with robust normalization strategies</article-title>. <source/>BMC Bioinformatics. <year>2013</year>;<volume>14</volume>(<issue>1</issue>):<fpage>219</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2105-14-219</pub-id>
<pub-id pub-id-type="pmid">23837715</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref039">
<label>39</label>
<mixed-citation publication-type="journal"><name><surname>Sanders</surname><given-names>SJ</given-names></name>, <name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Willsey</surname><given-names>AJ</given-names></name>, <name><surname>Ercan-Sencicek</surname><given-names>AG</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Cicek</surname><given-names>AE</given-names></name>, <etal>et al</etal>
<article-title>Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci</article-title>. <source/>Neuron. <year>2015</year>;<volume>87</volume>(<issue>6</issue>):<fpage>1215</fpage>–<lpage>33</lpage>. Epub 2015/09/25. <pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.016</pub-id> ; PubMed Central PMCID: PMCPMC4624267<pub-id pub-id-type="pmid">26402605</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref040">
<label>40</label>
<mixed-citation publication-type="journal"><name><surname>van Aerle</surname><given-names>R</given-names></name>, <name><surname>Lange</surname><given-names>A</given-names></name>, <name><surname>Moorhouse</surname><given-names>A</given-names></name>, <name><surname>Paszkiewicz</surname><given-names>K</given-names></name>, <name><surname>Ball</surname><given-names>K</given-names></name>, <name><surname>Johnston</surname><given-names>BD</given-names></name>, <etal>et al</etal>
<article-title>Molecular mechanisms of toxicity of silver nanoparticles in zebrafish embryos</article-title>. <source/>Environ Sci Technol. <year>2013</year>;<volume>47</volume>(<issue>14</issue>):<fpage>8005</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1021/es401758d</pub-id> ; PubMed Central PMCID: PMCPMC3854648.<pub-id pub-id-type="pmid">23758687</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref041">
<label>41</label>
<mixed-citation publication-type="journal"><name><surname>Jasien</surname><given-names>JM</given-names></name>, <name><surname>Daimon</surname><given-names>CM</given-names></name>, <name><surname>Wang</surname><given-names>R</given-names></name>, <name><surname>Shapiro</surname><given-names>BK</given-names></name>, <name><surname>Martin</surname><given-names>B</given-names></name>, <name><surname>Maudsley</surname><given-names>S</given-names></name>. The <article-title>effects of aging on the BTBR mouse model of autism spectrum disorder</article-title>. <source/>Front Aging Neurosci. <year>2014</year>;<volume>6</volume>:<fpage>225</fpage>
<pub-id pub-id-type="doi">10.3389/fnagi.2014.00225</pub-id> ; PubMed Central PMCID: PMCPMC4150363.<pub-id pub-id-type="pmid">25225482</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref042">
<label>42</label>
<mixed-citation publication-type="journal"><name><surname>Livak</surname><given-names>KJ</given-names></name>, <name><surname>Shumittgen</surname><given-names>TD</given-names></name>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title>. <source/>Methods. <year>2001</year>; <volume>25</volume>: <fpage>402</fpage>–<lpage>408</lpage>. dio: <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id>
<pub-id pub-id-type="pmid">11846609</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref043">
<label>43</label>
<mixed-citation publication-type="journal"><name><surname>Ku</surname><given-names>HO</given-names></name>, <name><surname>Jeong</surname><given-names>SH</given-names></name>, <name><surname>Kang</surname><given-names>HG</given-names></name>, <name><surname>Pyo</surname><given-names>HM</given-names></name>, <name><surname>Cho</surname><given-names>JH</given-names></name>, <etal>et al</etal>
<article-title>Gene expression profiles and pathways in skin inflamation induced by three different sensitizers and an irritant</article-title>. <source/>Toxicol Lett. <year>2009</year>;<volume>190</volume>:<fpage>231</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2009.07.022</pub-id>
<pub-id pub-id-type="pmid">19647056</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref044">
<label>44</label>
<mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>R</given-names></name>, <name><surname>Samal</surname><given-names>S</given-names></name>, <name><surname>Routray</surname><given-names>S</given-names></name>, <name><surname>Dash</surname><given-names>R</given-names></name>, <name><surname>Dixit</surname><given-names>A</given-names></name>. <article-title>Identification of oral cancer related cadidate genes by integrating protein-protein interactions, gene ontology, pathway analysis and immunohistochemistry</article-title>. <source/>Scientific Reports. <year>2017</year>;<volume>7</volume>:<fpage>2472</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-02522-5</pub-id>
<pub-id pub-id-type="pmid">28559546</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref045">
<label>45</label>
<mixed-citation publication-type="journal"><name><surname>Stone</surname><given-names>RL</given-names></name>, <name><surname>Aimi</surname><given-names>J</given-names></name>, <name><surname>Barshop</surname><given-names>BA</given-names></name>, <name><surname>Jaeken</surname><given-names>J</given-names></name>, <name><surname>Van den Berghe</surname><given-names>G</given-names></name>, <name><surname>Zalkin</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>A mutation in adenylosuccinate lyase associated with mental retardation and autistic features</article-title>. <source/>Nat Genet. <year>1992</year>;<volume>1</volume>:<fpage>59</fpage>
<pub-id pub-id-type="doi">10.1038/ng0492-59</pub-id>
<pub-id pub-id-type="pmid">1302001</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref046">
<label>46</label>
<mixed-citation publication-type="journal"><name><surname>FE</surname><given-names>A.</given-names></name>, <name><surname>Julie</surname><given-names>S</given-names></name>, <name><surname>Catherine</surname><given-names>M</given-names></name>, <name><surname>Julio</surname><given-names>A</given-names></name>, <name><surname>SM</surname><given-names>I.</given-names></name>, <name><surname>Anne</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Adenylosuccinate lyase (ADSL) and infantile autism: Absence of previously reported point mutation</article-title>. <source/>Am J Med Genet. <year>1995</year>;<volume>60</volume>(<issue>6</issue>):<fpage>554</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320600614</pub-id>
<pub-id pub-id-type="pmid">8825895</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref047">
<label>47</label>
<mixed-citation publication-type="journal"><name><surname>Jurecka</surname><given-names>A</given-names></name>, <name><surname>Zikanova</surname><given-names>M</given-names></name>, <name><surname>Tylki-Szymanska</surname><given-names>A</given-names></name>, <name><surname>Krijt</surname><given-names>J</given-names></name>, <name><surname>Bogdanska</surname><given-names>A</given-names></name>, <name><surname>Gradowska</surname><given-names>W</given-names></name>, <etal>et al</etal>
<article-title>Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency</article-title>. <source/>Mol Genet Metab. <year>2008</year>;<volume>94</volume>(<issue>4</issue>):<fpage>435</fpage>–<lpage>42</lpage>. Epub 2008/06/06. <pub-id pub-id-type="doi">10.1016/j.ymgme.2008.04.013</pub-id> .<pub-id pub-id-type="pmid">18524658</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref048">
<label>48</label>
<mixed-citation publication-type="journal"><name><surname>S</surname><given-names>L</given-names></name>. <article-title>Getting to the bottom of autism spectrum and related disorders: MBD5 as a key contributor</article-title>. <source/>Clinical Genetics. <year>2012</year>;<volume>81</volume>(<issue>4</issue>):<fpage>363</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01836.x</pub-id>
<pub-id pub-id-type="pmid">22171639</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref049">
<label>49</label>
<mixed-citation publication-type="journal"><name><surname>Talkowski</surname><given-names>ME</given-names></name>, <name><surname>Mullegama</surname><given-names>SV</given-names></name>, <name><surname>Rosenfeld</surname><given-names>JA</given-names></name>, <name><surname>van Bon</surname><given-names>BW</given-names></name>, <name><surname>Shen</surname><given-names>Y</given-names></name>, <name><surname>Repnikova</surname><given-names>EA</given-names></name>, <etal>et al</etal>
<article-title>Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder</article-title>. <source/>Am J Hum Genet. <year>2011</year>;<volume>89</volume>(<issue>4</issue>):<fpage>551</fpage>–<lpage>63</lpage>. Epub 2011/10/11. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.09.011</pub-id> ; PubMed Central PMCID: PMCPMC3188839.<pub-id pub-id-type="pmid">21981781</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref050">
<label>50</label>
<mixed-citation publication-type="journal"><name><surname>Peca</surname><given-names>J</given-names></name>, <name><surname>Feliciano</surname><given-names>C</given-names></name>, <name><surname>Ting</surname><given-names>JT</given-names></name>, <name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Wells</surname><given-names>MF</given-names></name>, <name><surname>Venkatraman</surname><given-names>TN</given-names></name>, <etal>et al</etal>
<article-title>Shank3 mutant mice display autistic-like behaviours and striatal dysfunction</article-title>. <source/>Nature. <year>2011</year>;<volume>472</volume>(<issue>7344</issue>):<fpage>437</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/nature09965</pub-id> ; PubMed Central PMCID: PMCPMC3090611.<pub-id pub-id-type="pmid">21423165</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref051">
<label>51</label>
<mixed-citation publication-type="journal"><name><surname>Costa-Mattioli</surname><given-names>M</given-names></name>, <name><surname>Monteggia</surname><given-names>LM</given-names></name>. <article-title>mTOR complexes in neurodevelopmental and neuropsychiatric disorders</article-title>. <source/>Nat Neurosci. <year>2013</year>;<volume>16</volume>(<issue>11</issue>):<fpage>1537</fpage>–<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3546</pub-id> .<pub-id pub-id-type="pmid">24165680</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref052">
<label>52</label>
<mixed-citation publication-type="journal"><name><surname>Shih</surname><given-names>BB</given-names></name>, <name><surname>Nirmal</surname><given-names>AJ</given-names></name>, <name><surname>Headon</surname><given-names>DJ</given-names></name>, <name><surname>Akbar</surname><given-names>AN</given-names></name>, <name><surname>Mabbott</surname><given-names>NA</given-names></name>
<etal>et al</etal>
<article-title>Derivation of marker gene signatures from human skin and their use in the interpretation of the transcriptional changes associated with dermatological disorders</article-title>. <source/>J Pathol. <year>2017</year>;<volume>241</volume>:<fpage>600</fpage>–<lpage>613</lpage>. <pub-id pub-id-type="doi">10.1002/path.4864</pub-id>
<pub-id pub-id-type="pmid">28008606</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref053">
<label>53</label>
<mixed-citation publication-type="journal"><name><surname>Sztajnkrycer</surname><given-names>MD</given-names></name>. <article-title>Valproic acid toxicity: overview and management</article-title>. <source/>J Toxicol Clin Toxicol. <year>2002</year>;<volume>40</volume>:<fpage>789</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1081/CLT-120014645</pub-id>
<pub-id pub-id-type="pmid">12475192</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref054">
<label>54</label>
<mixed-citation publication-type="journal"><name><surname>Anitha</surname><given-names>A</given-names></name>, <name><surname>Nakamura</surname><given-names>K</given-names></name>, <name><surname>Thanseem</surname><given-names>I</given-names></name>, <name><surname>Yamada</surname><given-names>K</given-names></name>, <name><surname>Iwayama</surname><given-names>Y</given-names></name>, <name><surname>Toyota</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Brain region-specific altered expression and association of mitochondria-related genes in autism</article-title>. <source/>Mol Autism. <year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-12</pub-id>
<pub-id pub-id-type="pmid">23116158</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref055">
<label>55</label>
<mixed-citation publication-type="journal"><name><surname>Hollis</surname><given-names>F</given-names></name>, <name><surname>Kanellopoulos</surname><given-names>AK</given-names></name>, <name><surname>Bagni</surname><given-names>C</given-names></name>. <article-title>Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives</article-title>. <source/>Curr Opin Neurobiol. <year>2017</year>;<volume>45</volume>:<fpage>178</fpage>–<lpage>87</lpage>. Epub 2017/06/20. <pub-id pub-id-type="doi">10.1016/j.conb.2017.05.018</pub-id> .<pub-id pub-id-type="pmid">28628841</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref056">
<label>56</label>
<mixed-citation publication-type="journal"><name><surname>Siddiqui</surname><given-names>MF</given-names></name>, <name><surname>Elwell</surname><given-names>C</given-names></name>, <name><surname>Johnson</surname><given-names>MH</given-names></name>. <article-title>Mitochondrial Dysfunction in Autism Spectrum Disorders</article-title>. <source/>Autism Open Access. <year>2016</year>;<volume>6</volume>(<issue>5</issue>). Epub 2016/12/09. <pub-id pub-id-type="doi">10.4172/2165-7890.1000190</pub-id> ; PubMed Central PMCID: PMCPMC5137782.<pub-id pub-id-type="pmid">27928515</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref057">
<label>57</label>
<mixed-citation publication-type="journal"><name><surname>Schneider</surname><given-names>T</given-names></name>, <name><surname>Przewlocki</surname><given-names>R</given-names></name>. <article-title>Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism</article-title>. <source/>Neuropsychopharmacology. <year>2005</year>;<volume>30</volume>(<issue>1</issue>):<fpage>80</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1300518</pub-id> .<pub-id pub-id-type="pmid">15238991</pub-id></mixed-citation>
</ref>
<ref id="pone.0203543.ref058">
<label>58</label>
<mixed-citation publication-type="journal"><name><surname>Beker van Woudenberg</surname><given-names>A</given-names></name>, <name><surname>Snel</surname><given-names>C</given-names></name>, <name><surname>Rijkmans</surname><given-names>E</given-names></name>, <name><surname>de Groot</surname><given-names>D</given-names></name>, <name><surname>Bouma</surname><given-names>M</given-names></name>, <name><surname>Hermsen</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Zebrafish embryotoxicity test for developmental (neuro)toxicity: Demo case of an integrated screening approach system using anti-epileptic drugs</article-title>. <source/>Reprod Toxicol. <year>2014</year>;<volume>49</volume>:<fpage>101</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.reprotox.2014.07.082</pub-id> .<pub-id pub-id-type="pmid">25111975</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>